Form 4 for CVS CVS Health
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001127602-24-012275 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | 2024-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $79.56 | +10.7K | 15.1K | +241% | +$849.9K | |
| M | 2024-04-03 | 2024-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $79.56 | -3,004 | 9,592 | -24% | -$239.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (Restricted) | 2024-04-01 | A | A | 10,683 | $79.56 | 15,109 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-01 | F | D | 1,112 | $79.56 | 8,480 | D | — | — | |
| 3 | Common | Common Stock | 2024-04-01 | F | D | 1,892 | $79.56 | 9,592 | D | — | — |